Behbahani Ali

Arcellx, Inc. · Director

Behbahani Ali is listed in public filings as director. This Behbahani Ali insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Arcellx, Inc. (ACLX), Korro Bio, Inc. (KRRO), Adaptimmune Therapeutics plc (ADAPY), Monte Rosa Therapeutics, Inc. (GLUE), and CRISPR Therapeutics AG-Common Shares (CRSP). Investors use Behbahani Ali's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Adaptimmune Therapeutics plcADAPY$176k14.7M sharesSellAug 18, 2025$0.012--